Week 4 Flashcards

1
Q

Defining contraception

A

Aims to prevent pregnancy
Achieved by preventing:
-ovulation
-fertilisation
-implantation
Pregnancy occurs at implantation- contraception does not include abortifacients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Why is contraception important

A

30% pregnancies unplanned
Spacing pregnancy improves outcome
Prevent pregnancy related risk
Choice/empowerment/human rights
Lower teenage pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Background fertility

A

<35 years 80-90 pregnancies per 100 women per year
55 years natural conceptions are rare

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Failure rates

A

No method is 100% effective
Effectiveness of some methods depends on correct and consistent use
Pearl index= failure rate per 100 women years of exposure
-if 100 women use the method for a year x will become pregnant
Typical use- failure rate when used as in real life -not always correct
-perfect use- failure rate when method used consistently and correctly at all times

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Types of contraception

A

Methods with no user failure:
-copper coil (CuIUD)- copper
-hormonal coil (LNGIUD)- levonorgestrel
-implant
-sterilisation
Methods with user failure:
-barrier- external and internal condoms, diaphragm
-hormonal- combined pill/ patch/ ring, POP, injectables
-natural family planning and lactational amenorrhoea
Emergency contraception

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

For each contraceptive method the key things to know are

A

What it is/what it contains
How it’s used
How does it work- mode of action
How well does it work- failure rate
How long does it work for- duration
Advantages and disadvantages
Any major contraindications- refer to the UKMEC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

UK medical eligibility criteria

A

Defines the safety of a contraceptive for individuals with certain characteristics, physical states or medical conditions
Does not advise on best methods nor effectiveness
1- condition for which theres no restriction for use
2-advantages of using methods generally outweigh theoretical or proven risks
3- condition where theoretical or proven risks usually outweigh advantages of using method
4- condition which represents an unacceptable health risk if method used

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Long acting reversible contraception

A

Methods that require administration less than once per cycle or month
Effectiveness does not depend on memory/user
More effective
Longer lasting
Convenient
Cost effective
-hormonal coil LNGIUD
-copper coil CuIUD
-implant
-injectable
All are fully reversible with no long term impact on fertility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Implants

A

Nexplanon subdermal implant
Etonogestrel (progesterone)
Single rod
Duration- 3 years
Mode of action
-inhibition of ovulation
-thickened cervical mucus
Failure rate- typical and perfect use= 0.03%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Implants advs and disadvs

A

Advantages:
-highly effective and reversible
-reduce HMB and dysmenorrhea may cause amenorrhoea
-quick return of fertility when removed
Disadvantages/side effects:
-fitting and removal procedure required
-irregular menstrual bleeding
-hormonal side effects- headache, breast tenderness, changes to skin, mood changes
-affected by enzyme inducers
-no STI protection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Hormonal coils LNGIUD

A

Small plastic T shaped device- inserted into the uterus, short threads for removal
Gradual release of progesterone levonorgesterel (LNG)
Mirena/levosert/benilexa/kyleena/jaydess
Mode of action
-thin endometrium
-thickens cervical mucus
-inhibits ovulation in some people
Duration of use: between 3-8 years depending on type
Effectiveness >99%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Hormonal coils advs and disadvs

A

Non contraceptive benefits:
-reduces menstrual bleeding/may induce amenorrhoea
-reduced dysmenorrhea
-may reduce pain from endometriosis or adenomyosis
Disadvantages:
-requires pelvic examination and speculum to fit
-hormonal- headache, breast tenderness, acne
-irregular bleeding- can last up to 9 months
-benign ovarian cysts
-ectopic risk if pregnancy does occur
-expulsion -<1:20
-no STI protection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Copper coil CuIUD

A

Small plastic T shaped device inserted into uterus, short threads for removal
Has copper on stem +/- banded arms
Mode of action:
-foreign body reaction in uterus- prevents implantation
-copper is toxic to sperm and ova
Duration use 5 or 10 years depending on device
Effectiveness >99%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Intrauterine device IUD

A

Advantages:
-effective immediately
-can be used as emergency contraception
-non hormonal
Disadvantages:
-requires pelvic exam and speculum to fit
-may increase menstrual blood loss
-may worsen dysmenorrhoea
-expulsion -<1:20
-Ectopic risk if pregnancy does occur
-no STI protection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Contraindications IUD

A

Refer to UKMEC for full list of
->48hr or <4wk postpartum
-post partum sepsis
-PID
-unexplained vaginal bleeding
-gestational trophoblastic disease
-cervical cancer
-cardiac arrhythmias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Injectables

A

Depo-provera: 150mgs depo medroxyprogesterone acetate IM 12-14 weekly
Sayana press: 104mg S/C 12-14 weekly
Mode of action:
-inhibit ovulation
-thicken cervical mucus
-thin endometrium
Effectiveness:
-perfect use >99%, typical use 96% due to late injections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Injectables advs and disadvs

A

Advantages:
-highly effective, convenient, reversible
-not affected by other medications/enzyme inducers
-reduces bleeding and pain, improved PMS
-reduces severity of sickle cell crises
Disadvantages:
-once given cannot be removed
-menstrual irregularities
-weight gain
-no STI protection
-may delay return of fertility- up to 1 year
-hormonal side effects- same as implants/POP
-decrease bone mineral density- returns after stopping

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Combined hormonal contraceptives

A

Contain oestrogen and progestogen
Pill
Patch
Vaginal ring
Mode of action:
-primary mode- prevent ovulation
-additional- thickens cervical mucus, endometrial thinning
Efficacy;
-perfect use- 0.3% failure
-typical use- 8% failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Combined pills COC

A

Contains 2 hormones
-oestrogen: ethinyl-oestradiol
-progestogen: synthetic progestogens
One pill per day
Same time each day
Missed pill rules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Combined patch Evra

A

Ethinyl oestradiol and norelgestromin
Transdermal
5x5cm adhesive patch
Pale pink
1 patch for 1 week for 3 weeks
Perfect use 1% failure, typical use 9% failure
Efficacy may be reduced if >90kg
Not affected by GI upsets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Combined vaginal ring Nuvaring

A

Ethinyl oestradiol and etonogestrel
Flexible transparent ring 54mm wide
Mode of action- inhibition of ovulation
One ring per 21 days
Removed for 7 days- withdrawal bleed
Not a LARC
Perfect use 1% failure
Typical use 9% failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Combined hormonal contraceptives

A

Benefits:
-regular, lighter, less painful periods
-reduced risk of ovarian/endometrial and colon cancer
-may reduce premenstrual symptoms
-may improve acne
Disadvantages/risks:
-venous or arterial thrombosis risk
-heart attack and stroke risk
-breast cancer- reduces with time after stopping the pill
-cervical cancer with longer use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Combined hormonal contraceptives side effects

A

Temporary: headaches, nausea, breast tenderness, mood changes
Breakthrough bleeding
Effectiveness affected by enzyme inducers
Pilll effectiveness affected by diarrhoea/vomiting
No STI protection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Combined hormonal contraceptives, oestrogen can increase risk of blood clots

A

Oestrogen containing contraceptives have more contraindications:
-high BMI
-migraines
-smoking
-age
-VTE <45 (patient or 1st degree relative)
-hypertension
-thrombophilias
How to take: standard- take for 21 days, 7 day break (hormone free interval)
Tailored regimens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Progestogen only pill
Synthetic progesterone -desogestrel/levonorgestrel/norethisterone/drospirenone Should be taken daily at the same time each day, every day No pill free interval Mode of action: -prevent ovulation -thicken cervical mucus -thin endometrium Failure rates: -perfect use 1% failure -typical use 9% failure Be aware- traditional vs desogestrel POPs
26
Progestogen only pill advs and disadvs
Benefits: -effective, reversible -now available OTC Disadvantages: -menstrual irregularities -same time each day- 12 hour window for desogestrel (3 hours traditional POPs) -functional ovarian cysts -hormonal (headaches, changes to mood, depression, bloating, breast tenderness)
27
Progestogen only methods
Much fewer contraindications than combined methods No increased stroke risk See UKMEC for full list -current breast cancer -severe liver disease/liver tumours -stroke/IHD
28
Barrier methods condoms
External condom: -latex/latex free, placed over an erect penis before any contact -acts as barrier to stop sperm entering the vagina -Perfect use 2% failure, typical 17% -single use only, check date, kite mark, not damaged, avoid -oil based lubricants, STI and HIV protection Internal condom: -inserted before sex, loosely lines vagina/rectum, partially covers vulva, acts as barrier to sperm -perfect use 5% fail, typical use 21% -single use only, STI and HIV protected
29
Barrier methods diaphragm
Reusable flexible latex or silicone device Put into vagina to cover cervix Acts as barrier to sperm Used with spermicide Can be inserted up to 3 hours before sex Needs to be left in for 6 hours after sex Perfect use 4-8% failure Typical use 12-29% failure Do not offer STI or HIV protection
30
Natural family planning
2 categories: -fertility awareness methods FAM -lactational amenorrhoea
31
Fertility awareness methods
Identify a fertile window and avoid UPSI around this time The main fertility indicators are which should be recorded daily: -basal body temperature -cervical secretions (cervical mucus) -the length of your menstrual cycle Failure rate between 1-25% Apps available
32
Fertility awareness methods advs and disadvs
Advantages: -can be used to avoid pregnancy or plan for one -no physical side effects -in couples control/may improve communication -avoids hormones/devices -acceptable to all faiths/cultures Disadvantages: -there are much more reliable methods -need to have regular cycles -takes 3-6 menstrual cycles to learn effectively -traditionally time consuming, requires high motivation -illness, lifetsyle, stress or travel may make fertility indicators harder to interpret -need to avoid sex or use condoms during fertile time -no STI protection
33
Lactational amenorrhoea
For post partum women -baby <6m old -woman must be amenorrhoeic -exclusively breast feeding- 4hrly in day, 6hrly at night If all 3 criteria are met: -typical failure rate -2% -perfect use failure rate -0.5%
34
Sterilisation male
Male- vasectomy -cutting /tying vas deferens Failure rate 1 in 2000 Permanent and irreversible on NHS Doesn’t affect sex drive or erections Ejaculation occurs but no longer contains sperm Use contraception for 8-12 weeks after until semen analysis
35
Female sterilisation
Works by tubal occlusion- preventing egg and sperm meeting -filshie clips -salpingectomy Failure rate 1 in 200 Permanent and irreversible on NHS Age/parity is not a restriction
36
Emergency contraception
To be given after sex 2 categories: copper IUD- gold standard, oral methods: ulipristal acetate (ellaOne), levonorgestrel (levonelle) Copper IUD: -can be inserted up to 120 hours after first UPSI -or within 5 days of the earliest expected ovulation -overall efficacy 99.9%, benefits and risks as for non emergency copper IUD -can be used for ongoing contraception or removed once pregnancy excluded
37
Emergency contraception pill
Ulipristal acetate: -current brand ellaOne single 30mg tablet, licensed for up to 120 hours after sex -synthetic progesterone receptor modulator -primary mode of action- delays ovulation Prevents about 60-80% of expected pregnancies Effectiveness decreased by progestogen contraception used 7 days before or 5 days after Can be used multiple times per cycle Levonorgestrel: -single tablet- 1.5mg levonorgestrel (3mg if BMI>26) -efficacy up to 96 hours -high dose progesterone- delays ovulation -use >72 hours outside the produce licence -efficacy approx 60% -can use multiple times per cycle
38
Menopause
Defined as the cessation of menses for: -12 months >50 years -24 months <50 years Average age menopause in UK is 51 Early menopause <45 Premature ovarian insufficiency <40 years
39
Menopausal symptoms
Occur due to reduced oestrogens Hot flushes and night sweats Loss of libido Vaginal dryness Skin dryness/dry hair/thinner hair Frequency of micturition, urgency, nocturia Lethargy and fatigue Low mood/anxiety Arthralgia/myalgia Poor sleep/insomnia Palpitations
40
Long term effects of oestrogen deficiency
Increased cardiovascular risk: -MI -stroke Reduction in bone mineral density Increased total cholesterol and LDL cholesterol Decreased glucose tolerance and insulin sensitivity
41
Hormone replacement therapy
Types HRT: -with a uterus —combined oestrogen and progestogen —-cyclical (sequential) —-continuous Without a uterus --oestrogen only
42
HRT routes
Transdermal: patch, gel, spray Oral LNGIUD- as progestogen component of HRT Implants Low dose vaginal oestrogen for vaginal symptoms (can be used with systemic HRT)
43
HRT risk and benefits
Benefits: -eases symptoms -reduces cardiovascular risk as long as started within 10 years menopause -protects bone mineral density Risks; -transdermal HRT has a safer risk profile than oral -oral preparations: DVT/PE risk, stroke and MI risk -increased risk of breast cancer 1 per 1000 per year, needs to be considered in context Risk of endometrial cancer is unopposed oestrogen is given to women with a uterus HRT is not a contraceptive
44
Formation of placenta
1st trimester
45
Receptive endometrium
Mid-luteal phase: -secretory activity peaks- endometrial cells rich in glycogen and lipids ~14mm thick -glands increase in number and size -maintained by high progesterone and oestrogen levels -endometrial receptivity is marked by changes on surface epithelium
46
Implantation window
Pinopode formation day 16-20, reduce volume of uterus
47
Implantation
Embryo attached and penetration of the endometrium and maternal circulatory system to form the placenta Embryo enters uterus bathed in the uterine secretions for 1-3 days prior to hatching from the zona pellucida “Apposition”= blastocyst loosely associates with uterine wall “Attachment”= firm adhesion “Invasion”= blastocyst attachment to the uterine wall triggers enzyme production. -degrades and invades the glycogen rich endometrial stroma -provides further nutritional support
48
Decidualisation of the endometrium
Induced by progesterone Oedema, changes in ECM, vascular remodelling/angiogenesis , leukocyte infiltration (uNK cells) -uterine natural killer cells- set up environment to remodel endoemetrium, recognise embryo allowing tolerance to embryo Endometrial stromal cells undergo morphological and biochemical changes -fibroblast like-> polygonal (epithelial like) Store glycogen and lipids support blastocyst Secrete decidual proteins (characteristic markers): prolactin, IGFBP-1, tissue factor, VEGF, PIGF, LIF, IL-15 The decidua completely surrounds the implanted blastocyst by day ~10. Most is shed at parturition
49
Placenta
Plakous- flat cake At term-discoid 15-25cm, 2.5-3cm thick, 500g
50
Structure of the placenta
Chorionic plate: you have layer of vascularised fetal tissue (the chorion) that goes across. From there the umbilical cord arises with vessels that go off to the fetus From the maternal side: the endometrium comes around the placenta, you have lots of intervillous spaces, this is where maternal blood pools and circulates around chorionic villi Functional units of placenta- cotyledon/lobe, placental septum’s Some villi make contact with other side- anchoring villi Maternal blood transferred through whole thing from spiral arteries from endometrium to allow for exchange nutrients and gases to fetus via villi then drain back via endometrial veins
51
Placental classification
3 main types based on structural organisation and separation of fetal and maternal blood supplies Haemochorial- the chorion is in direct contact with the blood. Human placenta Endotheliochorial- the maternal blood vessel endothelium comes in direct contact with chorion (dog and cat) Epitheliochorial- the most primitive form- The maternal epithelium of the uterus comes into contact with the chorion (cows and pigs)
52
Trophoblast cells
Trophectoderm gives rise to 3 main types of trophoblast -cytotrophoblasts (villous cytotrophoblast) -fusion of these form syncytiotrophoblasts (multinucleate very invasive) Extravillous trophoblasts EVT: interstitial, or endovascular
53
Implanting embryo at ~day 15
O2 and nutrients reach the developing embryo by diffusion from the surrounding decidua (histiotrophic nutrition) The initial phases of development occur at low O2 tensions
54
Lacunae formation
Lacunae form in the syncytiotrophoblast Syncytiotrophoblast invades and erodes maternal capillaries These anastomose with trophoblast lacunae to form sinusoids Intervillous space develops Start of villous development
55
Primary villi
Day 11-13 cytotrophoblasts invade Cytotrophoblast extend invade into syncytiotrophoblast layer form finger like projections in the decidua Primary villi cover the entire surface of blastocyst
56
Secondary villi
Extra embryonic mesoderm (mesoblast) invades core of primary villous day 16 Mesoderm covers the entire surface of the chorionic sac Villi continue to extend into the decidua between the blood filled lacunae/sinusoids
57
Tertiary villi
Mesodermal cells differentiate to form endothelial cells and other cell types Blood vessels form an arteriocapillary network in the villi These vessels fuse with developing vessels in the stalk- to link the foetal blood system via invading vessels from the umbilical cord
58
Structure of mature placental villi
Stem villi- basal part of villi- attached to chorionic plate Branch/intermediate villi- project from sides of stem villi Terminal villi- swellings at the tips of branch villi contain terminal vessels- form convoluted knots where the majority of exchange takes place- continue to be produced throughout gestation The cytotrophoblast layer becomes very thin but remains mostly intact 80% coverage in full term placenta
59
Remodelling of the maternal blood vessels
Essential to establish a low resistance high flow blood supply to the intervillous space Critical for normal pregnancy Spiral arteries: -resistance vessels supplying the endometrium/decidua -coiled appearance in the inner myometrium and decidua -100-150 arteries are transformed -diameter is increased 10 fold
60
Extravillous trophoblast outgrowth
First trimester: -cytotrophoblast columns form at tips of anchoring villi -Extravillous trophoblasts EVT differentiate and form interstitial and endovascular EVT EVT invade the decidua and occlude the spiral arteries Replace the endothelium and smooth muscle cells forming the endovascular trophoblast layer Establish normal utero placental dynamics Anchoring villi- cross the intervillous space- migrate deeply and attach to maternal decidua EVT plug spiral arteries- reduce blood flow to the developing placenta Creates low oxygen environment- protects fetus from oxidative stress EVT plugs breakdown initiating blood flow to intervillous space>14 weeks UNK ~70% of inflammatory cells in decidua- produce many cytokines and initiate/promote remodelling Vessels remodel outwards, lay down lots fibroid material, ECM, rigid structures. SMC undergo apoptosis or de differentiate migrate away
61
Phases of nutrition
Histiotrophic phase: week 8 [O2]=20mmHg Placental perfusion- initiated week 12-14 Haemotrophic phases: week 14 [O2]=60mmHg
62
Maternal adaptations to meet the increasing oxygen/nutrient demand of the growing fetus
Increased maternal blood volume ~40% during first trimester Uterine blood flow increases ~20 fold during pregnancy via uterine (and ovarian) arteries Cardiac output increases by 30-40% ->25% cardiac output goes to placenta Heart rate increases 10-15bpm Increased ventilation rate
63
Fetal blood flow in placenta
Umbilical arteries (deoxygenated) Fetal capillaries within villi: stem villi, intermediate, terminal Umbilical vein (oxygenated)
64
Transport across the placenta
Parabiotic relationship between mother and fetus: -fetus is dependent on maternal provision of nutrition, O2, salts, organic precursors etc and removal waste products CO2, urea etc across the placenta Diffusion: O2, CO2, Na+, urea, fatty acids, sugars (facilitated), non conjugated steroids, thyroxine T4 Active transport: amino acids, iron, ca2+ Not transported: conjugated steroids most bacteria Harmful: cocaine, alcohol, caffeine, tetracycline,
65
Placental barrier
Haemotrophic nutrition >wk 14- maternal blood delivers nutrients to fetal circulation across the placenta ~3-4cell layers separate the maternal and fetal circulations: syncytiotrophoblast, cytotrophoblasts, connective tissue, fetal capillary endothelium The intervillous spaces of a mature placenta contains ~150ml of blood exchanged 3-4x every minute
66
Gas exchange across the placenta
O2 and CO2 by passive diffusion ~40% more haemoglobin in fetal blood vs adult Fetal haemoglobin ~80% late gestation Higher affinity for O2 achieves saturation at lower pO2 -pO2 40-50mmHg ~90% Fetal Hb staurated, ~60% adult Simultaneous movement of CO2 on a concentration gradient back to the mother Double Bohr effect results in increase of ph on fetal side- promotes uptake at lower PO2
67
Glucose carbohydrate metabolism
Uptake by insulin insensitive hexose transporters GLUT3 GLUT1 Maternal insulin regulates glucose- increases glycogen and adipose stores Maternal tissues show insulin insensitivity/resistance (due to human placental lactogen) promoting transfer of blood glucose to placenta Glucose is also metabolised to lactate which is used as an energy sourced by the fetus
68
Amino acids and urea
Fetus regulates maternal amino acids metabolism through progesterone Mother retains extra amino acids and transports them to fetal circulation Some are metabolised eg serine-> glycine Fetal urea diffuses passively into the maternal blood
69
Water and electrolytes
Exchange in water occurs in placenta and non placental chorion at the amnion- amniotic fluid increases from 15ml at 8 wks to 450ml at wk 20, net production decreases to 0 by wk 34 Na+ and other electrolytes transfer readily across placenta Iron: in fetal and maternal blood both free and bound to transferrin, enhanced absorption (10% 1st tri, to 30% 3rd) to cover loss to fetus, placenta, blood loss in labour Calcium: demand for fetal ossification in 3rd trimester, Ca2+ absorption is enhanced and transferred to fetal circulation Vitamins: folic acid and vit B12
70
The syncytiotrophoblast is the primary barrier
Lipids: extracellular lipases release fatty acids from maternal lipoproteins- intracellular binding proteins FABPs transport the fatty acids in the cytosol of the syncytiotrophoblast
71
Maternal antibodies
IgG transferred by pinocytosis Provide passive post natal immunity: -diphtheria -small pox -measles -chicken pox -whooping cough
72
Infectious agents that cross the placenta
Viruses: -CMV -rubella -coxsackie- hand foot and mouth -varicella -polio -HIV Bacteria: -spirochetes -syphilis, listeria, lymes disease Protozoa: -toxoplasma -toxoplasma gondii
73
Poor EVT invasions of the maternal spiral arteries
Migration of EVTs is under tight temporal-spatial control- disturbances in this process can result in significant loss of placental function IUGR/early onset pre-eclampsia due to insufficient penetration by EVTs shallow invasions of decidua Premature loss of EVT plugs in spiral arterioles- early initiation of blood flow to placenta may lead to miscarriage
74
Disturbed placental blood flow in placental insufficiency
Leads to high pressure flow Vasoconstriction- pulsatile flow Ischaemia reperfusion injury/oxidative stress Damage to villi Failure to fully remodel maternal spiral arterioles -in PE reduced external myometrial spiral artery diameter
75
Pre eclampsia
Maternal systemic syndrome caused by abnormal placentation in the first trimester- clinical symptoms present from 20 weeks onwards 3-5% pregnancies in west -severe early onset PE<32 weeks -0.5% ~30% PE cases associated with IUGR Only cure delivery placenta
76
Maternal symptoms of pre eclampsia
Symptoms develop in 2nd-3rd trimester <20wks Hypertension >140/90mmHg 2 readings >4hrs apart Proteinuria >300mg/l 2+ dipstick Headache HELLP (haemolysis, elevated liver enzymes, low platelets syndrome 20% cases) Disseminated intravascular coagulopathy DIC 20% HELLP cases Seizures- eclampsia Early onset <32wks tends to be more severe
77
Risk factors for PE
7-fold greater is previous PE pregnancy Maternal or paternal history PE Increased inter pregnancy interval Multiple gestation Maternal age>40 Insulin resistance, diabetes, obesity, metabolic syndrome, vascular inflammation, pre existing hypertension
78
Underlying pathology in pre eclampsia
Placenta: -abnormal trophoblast invasion -reduced differentiation and transport -altered trophoblast secretions -enhanced trophoblast apoptosis -increased fibrin deposition Maternal: systemic endothelial activation, systemic inflammatory response
79
Intra-uterine growth restriction IUGR
Occurs in 8-14% of normal pregnancies- associated with pregnancy induced hypertension particularly early onset PE Blood flow to both sides placenta compromised O2 passes across by simple diffusion- reduced flow leads to fetal hypoxia Glucose transfer is generally not affected by Reduced fatty acid transfer Amino acid transport compromised -lysine, taurine, leucine, phenylalanine reduced in fetal plasma Reduced ion transport Acidosis-increased fetal lactate levels Reduced bone mineralisation in 3rd trimester
80
Placenta previa
3-6 per 1000 Blastocyst usually implants high on posterior wall of uterus Increased risk of placental abruption/haemorrhage Marginal type II/III, complete IV, low lying I Classified as degree of coverage of cervix
81
Placenta accreta
Results from excessive trophoblast invasion Placenta invades and is inseparable from uterine wall 3 in 1000 Identified before parturition on US Can lead to vaginal bleeding in 3rd trimester Associated cases of placenta previa Associated with myometrial scarring from previous C sections Risk of maternal haemorrhage Pre term C section/hysterectomy